Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children.

Zhou W, Johnson TN, Xu H, Cheung S, Bui KH, Li J, Al-Huniti N, Zhou D.

CPT Pharmacometrics Syst Pharmacol. 2016 Sep;5(9):475-83. doi: 10.1002/psp4.12101. Epub 2016 Aug 27.

2.

The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.

Zamponi GW, Striessnig J, Koschak A, Dolphin AC.

Pharmacol Rev. 2015 Oct;67(4):821-70. doi: 10.1124/pr.114.009654. Review.

3.

Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.

Toth C.

Ther Adv Drug Saf. 2014 Feb;5(1):38-56. doi: 10.1177/2042098613505614. Review.

4.

Pregabalin in neuropathic pain: evidences and possible mechanisms.

Verma V, Singh N, Singh Jaggi A.

Curr Neuropharmacol. 2014 Jan;12(1):44-56. doi: 10.2174/1570159X1201140117162802.

5.
6.

Pregabalin in acute and chronic pain.

Baidya DK, Agarwal A, Khanna P, Arora MK.

J Anaesthesiol Clin Pharmacol. 2011 Jul;27(3):307-14. doi: 10.4103/0970-9185.83672.

7.

Pregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of ca(v)2.1 calcium channels.

Di Guilmi MN, Urbano FJ, Inchauspe CG, Uchitel OD.

J Pharmacol Exp Ther. 2011 Mar;336(3):973-82. doi: 10.1124/jpet.110.172171. Epub 2010 Dec 22.

8.

Drug interactions at the blood-brain barrier: fact or fantasy?

Eyal S, Hsiao P, Unadkat JD.

Pharmacol Ther. 2009 Jul;123(1):80-104. doi: 10.1016/j.pharmthera.2009.03.017. Epub 2009 Apr 22. Review.

10.

Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin.

Hendrich J, Van Minh AT, Heblich F, Nieto-Rostro M, Watschinger K, Striessnig J, Wratten J, Davies A, Dolphin AC.

Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3628-33. doi: 10.1073/pnas.0708930105. Epub 2008 Feb 25.

11.

New Horizons in the development of antiepileptic drugs: Innovative strategies.

Löscher W, Schmidt D.

Epilepsy Res. 2006 Jun;69(3):183-272.

Supplemental Content

Support Center